OHSU News

This email notification is intended as a heads up to OHSU communicators. It is not shared with external subscribers.

OHSU tests CRISPR gene-editing technology to treat deadly heart condition

OHSU tests CRISPR gene-editing technology to treat deadly heart condition

Ken Hawkins, a retired teacher from Grants Pass, is first Oregon participant in phase 3 clinical trial.